ZYCUBO FDA Approval: Survival Benefit in Menkes Disease
On January 12, 2026, the U.S. Food and Drug Administration (FDA) officially approved ZYCUBO® (copper histidinate) for injection, marking a historic achievement as the first and only approved treatment for Menkes disease in the United States. Developed by Sentynl Therapeutics,…